title: Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart.
abstract: Opiates have been used for thousands of years in the form of opium for relief of pain or fever and to induce sleep. However, it was only in the 1970s that the endogenous ligands for the opiate receptors were identified and termed opioid peptides. Opioid peptides activate G protein-coupled receptors in the central and autonomic nervous system, with marked effects on the regulation of pain perception, body temperature, respiration, heart rate and blood pressure. Cardiovascular regulatory effects of endogenous opioids were initially considered to originate from neural centres in the central nervous system, facilitating a regulatory role in neuro-transmission, as demonstrated by the presynaptic co-release from sympathetic neurones of norepinephrine with enkephalin or acetylcholine with enkephalin. However, opioid peptides of myocardial origin have also recently been shown to play a key role in local regulation of the heart. This brief review highlights the key features of the enkephalin opioids in the heart and the current understanding of their role in development, ageing, cardioprotection, hypertension, hypertrophy, and heart failure.
authors.affiliation: Cardiac Surgical Research Unit Melbourne, Australia.
authors.forename: Olivier W V
authors.initials: OW
authors.lastname: van den Brink
authors.forename: Lea M
authors.initials: LM
authors.lastname: Delbridge
authors.forename: Franklin L
authors.initials: FL
authors.lastname: Rosenfeldt
authors.forename: Daniel
authors.initials: D
authors.lastname: Penny
authors.forename: Donald S
authors.initials: DS
authors.lastname: Esmore
authors.forename: Deahne
authors.initials: D
authors.lastname: Quick
authors.forename: David M
authors.initials: DM
authors.lastname: Kaye
authors.forename: Salvatore
authors.initials: S
authors.lastname: Pepe